SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Instituto de Medicina Molecular, Cenix BioScience GmbH, and Alnylam Pharmaceuticals Discover New Targets in Malaria Infection with RNAi Technology